Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
AbbVie sees positive late-stage results for subcutaneous Skyrizi in Crohn’s

AbbVie sees positive late-stage results for subcutaneous Skyrizi in Crohn’s

Mar 2, 2026

Post navigation

Breckenridge launches Pomalidomide Capsules, strengthening its oncology portfolio

US BioTek Laboratories Completes Merger With NutriPATH Pathology

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: